抗肿瘤药物引起骨髓抑制中西医结合诊治专家共识

2021-11-15 中国临床肿瘤学会 临床肿瘤学杂志

80%以上的化疗药物能导致骨髓抑制[1],以中性粒细胞、血小板减少为主,化疗相关性贫血的发生率约为70%~90%。 

中文标题:

抗肿瘤药物引起骨髓抑制中西医结合诊治专家共识

发布机构:

中国临床肿瘤学会

发布日期:

2021-11-15

简要介绍:

骨髓抑制是传统化疗药物引起的最常见的血液学毒性,新型抗肿瘤药物如靶向、免疫药物亦可引起,临床表现为外周血细胞数量减少,包括中性粒细胞减少、血小板减少和血红蛋白降低(贫血),三者可以单独出现,也可相互兼夹,通常发生在抗肿瘤药物治疗后。80%以上的化疗药物能导致骨髓抑制[1],以中性粒细胞、血小板减少为主,化疗相关性贫血的发生率约为70%~90%[2]。 

相关资料下载:
[AttachmentFileName(sort=1, fileName=抗肿瘤药物引起骨髓抑制中西医结合诊治专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=1aca21c002313eca, title=抗肿瘤药物引起骨髓抑制中西医结合诊治专家共识, enTitle=, guiderFrom=临床肿瘤学杂志, authorId=0, author=, summary=80%以上的化疗药物能导致骨髓抑制[1],以中性粒细胞、血小板减少为主,化疗相关性贫血的发生率约为70%~90%。 , cover=https://img.medsci.cn/202216/1641448076596_5579292.png, journalId=0, articlesId=null, associationId=2279, associationName=中国临床肿瘤学会, associationIntro=中国临床肿瘤学会(CSCO)中西医结合专家委员会, copyright=0, guiderPublishedTime=Mon Nov 15 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">骨髓抑制是传统化疗药物引起的最常见的血液学毒性,新型抗肿瘤药物如靶向、免疫药物亦可引起,临床表现为外周血细胞数量减少,包括中性粒细胞减少、血小板减少和血红蛋白降低(贫血),三者可以单独出现,也可相互兼夹,通常发生在抗肿瘤药物治疗后。80%以上的化疗药物能导致骨髓抑制</span><sup style="color: #333333;">[1]</sup><span style="color: #333333;">,以中性粒细胞、血小板减少为主,化疗相关性贫血的发生率约为70%~90%</span><sup style="color: #333333;">[2]</sup><span style="color: #333333;">。&nbsp;</span></p>, tagList=[TagDto(tagId=282, tagName=化疗), TagDto(tagId=4508, tagName=骨髓抑制), TagDto(tagId=6223, tagName=抗肿瘤药物)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=4508, guiderKeyword=骨髓抑制, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=49327, appHits=251, showAppHits=0, pcHits=1253, showPcHits=49076, likes=0, shares=36, comments=15, approvalStatus=1, publishedTime=Thu Jan 06 13:43:20 CST 2022, publishedTimeString=2021-11-15, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Thu Jan 06 13:45:01 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 16:22:02 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=抗肿瘤药物引起骨髓抑制中西医结合诊治专家共识.pdf)])
抗肿瘤药物引起骨髓抑制中西医结合诊治专家共识.pdf
下载请点击:
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1197676, encodeId=6ec2119e67615, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60445479842, createdName=ms2000000529313829, createdTime=Sun Feb 27 09:40:29 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194293, encodeId=359911942937f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220112/bf73f3305cad43df9d8c6383e4c80a11/dd38f5d3971d483f90e3f37da7df323a.jpg, createdBy=13b76462298, createdName=ms尼, createdTime=Thu Feb 17 08:13:11 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194164, encodeId=2a74119416450, content=呵呵, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33d71335965, createdName=youe520, createdTime=Wed Feb 16 21:58:46 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188155, encodeId=1dc4118815531, content=支援学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efbc6483265, createdName=ms9000001920539650, createdTime=Tue Jan 25 22:53:43 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185256, encodeId=19b011852569c, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmhead/fFgUJknhibCy1mxLxGwk0ndVfWXmBh8AOibSFDqsSgnoeicu2QjNDYn0g/0, createdBy=c24f1943525, createdName=覃医生, createdTime=Mon Jan 17 17:13:00 CST 2022, time=2022-01-17, status=1, ipAttribution=)]
    2022-02-27 ms2000000529313829

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1197676, encodeId=6ec2119e67615, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60445479842, createdName=ms2000000529313829, createdTime=Sun Feb 27 09:40:29 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194293, encodeId=359911942937f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220112/bf73f3305cad43df9d8c6383e4c80a11/dd38f5d3971d483f90e3f37da7df323a.jpg, createdBy=13b76462298, createdName=ms尼, createdTime=Thu Feb 17 08:13:11 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194164, encodeId=2a74119416450, content=呵呵, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33d71335965, createdName=youe520, createdTime=Wed Feb 16 21:58:46 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188155, encodeId=1dc4118815531, content=支援学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efbc6483265, createdName=ms9000001920539650, createdTime=Tue Jan 25 22:53:43 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185256, encodeId=19b011852569c, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmhead/fFgUJknhibCy1mxLxGwk0ndVfWXmBh8AOibSFDqsSgnoeicu2QjNDYn0g/0, createdBy=c24f1943525, createdName=覃医生, createdTime=Mon Jan 17 17:13:00 CST 2022, time=2022-01-17, status=1, ipAttribution=)]
    2022-02-17 ms尼

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1197676, encodeId=6ec2119e67615, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60445479842, createdName=ms2000000529313829, createdTime=Sun Feb 27 09:40:29 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194293, encodeId=359911942937f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220112/bf73f3305cad43df9d8c6383e4c80a11/dd38f5d3971d483f90e3f37da7df323a.jpg, createdBy=13b76462298, createdName=ms尼, createdTime=Thu Feb 17 08:13:11 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194164, encodeId=2a74119416450, content=呵呵, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33d71335965, createdName=youe520, createdTime=Wed Feb 16 21:58:46 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188155, encodeId=1dc4118815531, content=支援学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efbc6483265, createdName=ms9000001920539650, createdTime=Tue Jan 25 22:53:43 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185256, encodeId=19b011852569c, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmhead/fFgUJknhibCy1mxLxGwk0ndVfWXmBh8AOibSFDqsSgnoeicu2QjNDYn0g/0, createdBy=c24f1943525, createdName=覃医生, createdTime=Mon Jan 17 17:13:00 CST 2022, time=2022-01-17, status=1, ipAttribution=)]
    2022-02-16 youe520

    呵呵

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1197676, encodeId=6ec2119e67615, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60445479842, createdName=ms2000000529313829, createdTime=Sun Feb 27 09:40:29 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194293, encodeId=359911942937f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220112/bf73f3305cad43df9d8c6383e4c80a11/dd38f5d3971d483f90e3f37da7df323a.jpg, createdBy=13b76462298, createdName=ms尼, createdTime=Thu Feb 17 08:13:11 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194164, encodeId=2a74119416450, content=呵呵, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33d71335965, createdName=youe520, createdTime=Wed Feb 16 21:58:46 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188155, encodeId=1dc4118815531, content=支援学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efbc6483265, createdName=ms9000001920539650, createdTime=Tue Jan 25 22:53:43 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185256, encodeId=19b011852569c, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmhead/fFgUJknhibCy1mxLxGwk0ndVfWXmBh8AOibSFDqsSgnoeicu2QjNDYn0g/0, createdBy=c24f1943525, createdName=覃医生, createdTime=Mon Jan 17 17:13:00 CST 2022, time=2022-01-17, status=1, ipAttribution=)]
    2022-01-25 ms9000001920539650

    支援学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1197676, encodeId=6ec2119e67615, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60445479842, createdName=ms2000000529313829, createdTime=Sun Feb 27 09:40:29 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194293, encodeId=359911942937f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220112/bf73f3305cad43df9d8c6383e4c80a11/dd38f5d3971d483f90e3f37da7df323a.jpg, createdBy=13b76462298, createdName=ms尼, createdTime=Thu Feb 17 08:13:11 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194164, encodeId=2a74119416450, content=呵呵, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33d71335965, createdName=youe520, createdTime=Wed Feb 16 21:58:46 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188155, encodeId=1dc4118815531, content=支援学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efbc6483265, createdName=ms9000001920539650, createdTime=Tue Jan 25 22:53:43 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185256, encodeId=19b011852569c, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmhead/fFgUJknhibCy1mxLxGwk0ndVfWXmBh8AOibSFDqsSgnoeicu2QjNDYn0g/0, createdBy=c24f1943525, createdName=覃医生, createdTime=Mon Jan 17 17:13:00 CST 2022, time=2022-01-17, status=1, ipAttribution=)]
    2022-01-17 覃医生

    学习学习

    0